Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.0T | 1.1T | 1.0T | 1.1T |
Cost of revenue | 658.4B | 684.5B | 634.3B | 658.8B |
Gross profit | 342.1B | 377.5B | 382.7B | 402.6B |
Operating expense | ||||
Research & development | — | 121.2B | 137.7B | 119.0B |
Selling general and admin | 279.4B | 126.6B | 119.2B | 121.6B |
Other operating expenses | — | — | — | — |
Operating income | 342.1B | 89.7B | 87.1B | 123.2B |
Non operating interest income | ||||
Income | — | 16.6B | 16.6B | 16.5B |
Expense | — | 2.4B | 3.0B | 3.3B |
Other income expense | — | — | — | — |
Pretax income | 77.2B | 122.8B | 106.1B | 138.5B |
Tax provision | 8.6B | 12.5B | 2.1B | 2.9B |
Net income | 68.7B | 110.3B | 104.1B | 135.5B |
Basic EPS | 18.3K | 29.8K | — | 36K |
Diluted EPS | 18.3K | 29.8K | — | 36K |
Basic average shares | — | 3.2M | — | 3.2M |
Diluted average shares | — | 3.2M | — | 3.2M |
EBITDA | 342.1B | 273.0B | 261.8B | 291.8B |
Net income from continuing op. | — | 110.3B | 104.1B | 135.5B |
Minority interests | -2.4B | -2.6B | -2.4B | -4.3B |
Preferred stock dividends | — | — | — | — |